neonatal jaundice. Neonatal jaundice from other and unspecified causes
Conditions
Interventions
Intervention 1: Internention group A recieve
dissolved oral ursobil 10mg/kg in addition to phototherapy. Intervention 2: Intervention group B recieve
dissolved oral ursobil 15mg/kg in addition to phot
Treatment - Drugs
Internention group A recieve
dissolved oral ursobil 10mg/kg in addition to phototherapy
Intervention group B recieve
dissolved oral ursobil 15mg/kg in addition to phototherapy
Control group recieve
water plus phototherapy
Sponsors
Research vice chancellor of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Days to 15 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria: Birth weight more than 2500 grams; gestation age more than 35 weeks; age above 3 days less than 2 weeks; total serum bilirubin 14-20 mg/dl; direct bilirubin less than 2 mg/dl. Exclusion criteria: ABO incompatibility; Rh immunization; G6PDdefficiency; direct hyperbilirubinemia; sepsis; Crigler-Najjar syndrome; thyroid disorders; hepatic diseases; prematurity; infant of diabetic mother .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate of bilirubin decrease. Timepoint: 6,12,24 and 48 hours after starting treatment. Method of measurement: Measurment of total serum bilirubin. | — |
Secondary
| Measure | Time frame |
|---|---|
| The duration of hospitalization. Timepoint: From admission til discharge. Method of measurement: The hours and days of admission. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfsane Mokhaleg Sani
Tabriz University of Medical Sciences
Outcome results
None listed